mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.6 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.6 |